Final agreement between Navamedic and Grünenthal for Glucodmed/Flexove marketing in Mexico
Navamedic ASA and Grünenthal GmbH have signed the final agreement for marketing and distribution of Glucomed/Flexove in Mexico.
On the 22 February 2007, Navamedic ASA announced that it had entered into a Heads of Agreement with Grünenthal for marketing and distribution of Glucomed/Flexove in Mexico. It was announced that the final agreement was expected to be formally signed within 30.04.2007. The companies have now issued and signed the final agreement. The agreement has a duration of 10 years.
Grünenthal has already started the product approval process for Glucomed/Flexove. Product launch is expected within 2008.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.